Abstract

<p><strong>Objective</strong>: Based on the global burden of disease (GBD) 2019 study, to analyze the epidemic trend and risk factors of cardiovascular disease (CVD) in China by comparing the world, the United States, Japan and India. Methods data were obtained from the global health data exchange (ghdx) database. The prevalence, morbidity, mortality, disability adjusted life year (DALY) and other disease burden status and main risk factors of CVD in China were analyzed by sex and age; the age standardized rate was used to compare the change trend of CVD disease burden in China, the United States, Japan and India from 1990 to 2019. <strong>Results</strong>: In 2019, the number of CVD patients in China was 12 billion, with 123.41 million new cases and 458.43 million deaths; the prevalence, incidence rate, mortality and Daly rates increased from 423,543/100,000, 44,781/100,000, 20,475/100,000 and 509,103/100,000 in 1990 to 84,608/100,000, 86,765/100,000, 32,230/100,000 and 646,347/100,000 in 2019 respectively. The prevalence, incidence rate, mortality and Daly rate increased with age, and the burden of CVD in men was higher than that in women. In addition, the top 4 risk factors for CVD in China in 2019 are hypertension, diet, air pollution and tobacco, which lead to higher CVD disease burden than the global average. <strong>Conclusion</strong>: due to hypertension, dietary factors, air pollution, tobacco and other reasons, coupled with the rapid aging of the population, the disease burden of CVD in China is still very serious, which needs to be paid attention to by relevant departments.</p>

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.